Pfizer Backs Down from Drug Price Hike After Trump's Twitter Lashing

Health Leaders Media: In a surprising reversal, pharmaceutical giant Pfizer said Tuesday it would back down from planned price hikes for several dozen of its drugs amid heavy criticism from the White House.

After weathering a one-two punch Monday from the president and his Health and Human Services secretary, who took turns publicly lambasting the company, Pfizer appeared to have escaped unscathed, at least in terms of its performance on Wall Street.

Read article